Passa al contenuto
Merck

Vai a

07-689

Anti-EZH2 Antibody

Upstate®, from rabbit

Sinonimo/i:

KMT6, Enx1, Enhancer of Zeste Homologue 2

Autenticati per visualizzare i prezzi organizzativi e contrattuali.

Scegli un formato

Cambia visualizzazione
Taglio della confezioneSKUDisponibilitàPrezzo
200 μL

Spedizione prevista il28 maggio 2026daMerck S.p.A

570,00 €

Informazioni su questo articolo

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
polyclonal
Application:
ChIP, IP, WB
Citations:
66

570,00 €


Spedizione prevista il28 maggio 2026Dettagli

Per il tuo target è disponibile un anticorpo ricombinante privo di conservanti. Prova ZRB1095

Richiedi un ordine in blocco
Servizio Tecnico
Hai bisogno di aiuto? Il nostro team di scienziati qualificati è a tua disposizione.
Permettici di aiutarti


biological source

rabbit

Quality Segment

conjugate

unconjugated

antibody form

whole antiserum

antibody product type

primary antibodies

clone

polyclonal

species reactivity

human, mouse

packaging

antibody small pack of 25 μL

manufacturer/tradename

Upstate®

technique(s)

ChIP: suitable (ChIP-seq), immunoprecipitation (IP): suitable, western blot: suitable

NCBI accession no.

UniProt accession no.

shipped in

ambient

target post-translational modification

unmodified

Gene Information

human ... EZH2(2146)

General description

95-100kDa
Polycomb protein group complexes are responsible for the regulation of hundreds of genes in mammals and insects. These proteins are responsible for the assembly and packaging of chromatin and for the induction of methylation on Histone H3. EZH2 (enhancer of zeste homologue 2) is a member of the polycomb group of proteins and is involved in cell cycle regulation. EZH2 represses transcription via trimethylation of histone H3 on Lys27 (H3K27) as indicated by the fact that RNAi-mediated knockdown of EZH2 resulted in a loss of H3K27 trimethylation. The expression of this protein in human tumors is aggressive for hormone refractory prostate cancer. In breast cancer EZH2 expression was increased in malignant tumors and promoted anchorage independent and invasive growth in vitro.

Immunogen

His-tagged fusion protein corresponding to residues 1-343 of mouse enhancer of Zeste homolog 2 (EZH2)

Application

Research Category
Epigenetics & Nuclear Function
Research Sub Category
Histones
This Anti-EZH2 Antibody is validated for use in Immunoprecipitation and Western Blotting and ChIP-seq for the detection of EZH2.

Biochem/physiol Actions

EZH2

Physical form

Antiserum
Format: Purified

Preparation Note

stable for 2 years at 2-8°C from date of shipment

Analysis Note

Control
K562 cell lysate, C2C12 cell lysate
routinely evaluated by immunoblot on RIPA lysates from HeLa and C2C12 cells

Other Notes

Please refer to lot specific datasheet.

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Confronta articoli simili

Visualizza il confronto per intero

Mostra le differenze

1 of 1

Questo articolo
ABE28107-156205-1319
biological source

rabbit

biological source

rabbit

biological source

rabbit

biological source

mouse

antibody form

whole antiserum

antibody form

affinity isolated antibody

antibody form

serum

antibody form

purified immunoglobulin

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

species reactivity

human, mouse

species reactivity

human, mouse

species reactivity

rat, mouse, human

species reactivity

human, mouse

clone

polyclonal

clone

polyclonal

clone

polyclonal

clone

BD43, monoclonal

shipped in

ambient

shipped in

wet ice

shipped in

wet ice

shipped in

wet ice


Still not finding the right product?

Explore all of our products under Anti-EZH2 Antibody

o

Provate il nostro Motore di ricerca dei prodotti per restringere le opzioni.


Classe di stoccaggio

12 - Non Combustible Liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable



Certificati d'analisi (COA)

Cerca il Certificati d'analisi (COA) digitando il numero di lotto/batch corrispondente. I numeri di lotto o di batch sono stampati sull'etichetta dei prodotti dopo la parola ‘Lotto’ o ‘Batch’.

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti


Contenuto correlato

Cancer is a complex disease manifestation. At its core, it remains a disease of abnormal cellular proliferation and inappropriate gene expression. In the early days, carcinogenesis was viewed simply as resulting from a collection of genetic mutations that altered the gene expression of key oncogenic genes or tumor suppressor genes leading to uncontrolled growth and disease (Virani, S et al 2012). Today, however, research is showing that carcinogenesis results from the successive accumulation of heritable genetic and epigenetic changes. Moreover, the success in how we predict, treat and overcome cancer will likely involve not only understanding the consequences of direct genetic changes that can cause cancer, but also how the epigenetic and environmental changes cause cancer (Johnson C et al 2015; Waldmann T et al 2013). Epigenetics is the study of heritable gene expression as it relates to changes in DNA structure that are not tied to changes in DNA sequence but, instead, are tied to how the nucleic acid material is read or processed via the myriad of protein-protein, protein-nucleic acid, and nucleic acid-nucleic acid interactions that ultimately manifest themselves into a specific expression phenotype (Ngai SC et al 2012, Johnson C et al 2015). This review will discuss some of the principal aspects of epigenetic research and how they relate to our current understanding of carcinogenesis. Because epigenetics affects phenotype and changes in epigenetics are thought to be key to environmental adaptability and thus may in fact be reversed or manipulated, understanding the integration of experimental and epidemiologic science surrounding cancer and its many manifestations should lead to more effective cancer prognostics as well as treatments (Virani S et al 2012).






Numero articolo commerciale globale

SKUGTIN
07-689-25UL04054839350474

Domande

Recensioni

Nessuna valutazione

Filtri attivi